Results 121 to 130 of about 16,844 (169)

Retraction notice to Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance: J Am Coll Cardiol 71 (2018) 969-979. [PDF]

J Am Coll Cardiol, 2020
Liu A, Wijesurendra RS, Liu JM, Forfar JC, Channon KM, Jerosch-Herold M, Piechnik SK, Neubauer S, Kharbanda RK, Ferreira VM.   +9 more
europepmc   +1 more source

Role of the central autonomic nervous system intrinsic functional organisation and psychosocial factors in primary microvascular angina and Takotsubo syndrome. [PDF]

Open Heart, 2020
Cattaneo MM, Pravatà E, Provenzi M, Moccetti M, Kaelin A, Sudano I, Biasucci L, Gallino C, Limoni C, Calanchini C, Gallino A, Crea F, Cattaneo M.   +12 more
europepmc   +1 more source

'Primary' Microvascular Angina: Clinical Characteristics, Pathogenesis and Management. [PDF]

Interv Cardiol, 2018
Lanza GA, De Vita A, Kaski JC.
europepmc   +1 more source

Increased levels of angiogenic factors in microvascular angina. [PDF]

Med Pharm Rep, 2019
Asl ER, Rasmi Y, Khadem-Ansari MH, Seyed-Mohammadzad M, Rostamzadeh A, Ghaffari F, Mokarizadeh N.   +6 more
europepmc   +1 more source

Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.

Am Heart J, 2020
Morrow AJ, Ford TJ, Mangion K, Kotecha T, Rakhit R, Galasko G, Hoole S, Davenport A, Kharbanda R, Ferreira VM, Shanmuganathan M, Chiribiri A, Perera D, Rahman H, Arnold JR, Greenwood JP, Fisher M, Husmeier D, Hill NA, Luo X, Williams N, Miller L, Dempster J, Macfarlane PW, Welsh P, Sattar N, Whittaker A, Connachie AM, Padmanabhan S, Berry C.   +29 more
europepmc   +1 more source

Echocardiographic measurement of epicardial adipose tissue thickness in patients with microvascular angina. [PDF]

Interv Med Appl Sci, 2019
Kalçık M, Yesin M, Güner A, Bayam E, Yetim M, Doğan T, Bekar L, Çelik O, Karavelioğlu Y.   +8 more
europepmc   +1 more source

Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance.

J Am Coll Cardiol, 2018
Liu A, Wijesurendra RS, Liu JM, Forfar JC, Channon KM, Jerosch-Herold M, Piechnik SK, Neubauer S, Kharbanda RK, Ferreira VM.   +9 more
europepmc   +1 more source

The effect of trimetazidine in the treatment of microvascular angina

International Journal of Angiology, 1999
Although the pathophysiology of microvascular angina is unclear, intracellular metabolic changes are believed to be the main factors. Trimetazidine has an intracellular metabolic effect in coronary insufficiency. The effect of trimetazidine in microvascular angina is unknown.
Nalbantgil S., Altintig A., Yilmaz H., Nalbantgil I., Önder R.   +4 more
openaire   +3 more sources

Treatment of the hypertensive patient with microvascular angina

Current Opinion in Cardiology, 1999
Syndrome X and microvascular angina are a heterogenous group of diseases. Several medications, including angiotensin-converting enzyme inhibitors, beta-blockers, and calcium-channel blockers, have been reported to be successful in the treatment of microvascular angina. Control of hypertension and regression of left ventricular hypertrophy are important
Ventura, Hector, Loyalka, Pranav, Smart, Frank W.   +2 more
openaire   +6 more sources

Microvascular Angina as a Cause of Ischemia: An Update

, 2018
Since initial reports over four decades ago, the diagnosis and the management of “microvascular angina” continue to be a troublesome dilemma for physicians. Microvascular angina is suspected in those patients presenting with angina or angina-like chest pain whose coronary angiograms show no evidence of obstructive coronary artery disease. Many of these
Cenko, Edina, Amaduzzi, Peter Louis, Bugiardini, Raffaele   +2 more
openaire   +3 more sources